Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Total Current Liabilities (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed Total Current Liabilities for 16 consecutive years, with $542.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities changed N/A year-over-year to $542.2 million, compared with a TTM value of $542.2 million through Sep 2025, changed N/A, and an annual FY2024 reading of $545.8 million, down 16.82% over the prior year.
  • Total Current Liabilities was $542.2 million for Q3 2025 at Amn Healthcare Services, down from $545.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $969.4 million in Q4 2021 and bottomed at $542.2 million in Q3 2025.
  • Average Total Current Liabilities over 5 years is $680.0 million, with a median of $648.7 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities skyrocketed 129.19% in 2021, then fell 23.52% in 2023.
  • Year by year, Total Current Liabilities stood at $969.4 million in 2021, then fell by 11.5% to $857.9 million in 2022, then dropped by 23.52% to $656.1 million in 2023, then fell by 16.82% to $545.8 million in 2024, then dropped by 0.66% to $542.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for AMN at $542.2 million in Q3 2025, $545.8 million in Q4 2024, and $623.9 million in Q1 2024.